X
Get new exclusive access to healthcare business reports & breaking news
Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.
Amgen announced May 2nd financial results for the first quarter 2024, and its shares soared right after the ...
Another patent contest is brewing between Big Pharma giants Amgen and Johnson & Johnson (J&J). Amgen has set ...
Recently, Amgen (NASDAQ: AMGN) announced that the FDA (Food and Drug Administration) has granted the company’s investigational KRASG12C ...
Amgen has agreed to buy Celgene Corporation’s psoriasis drug, Otezla for $13.4 billion in cash, a deal set ...
